Leukemia Research
Издатель: Elsevier · ISSN 0145-2126 · 51 статей
- Venetoclax and Azacitidine Combination for the treatment of Immune-Mediated Inflammatory Diseases associated with Myeloid Neoplasms
- Editorial Board
- From standardization to precision medicine: Evolution of European Leukemianet recommendations in Philadelphia-negative myeloproliferative neoplasms
- Construction and evaluation of a machine-learning-based prediction model for pneumonia in patients with acute leukemia
- Readmission in patients with hematologic malignancies: A systematic review and meta-analysis
- Identification and characterization of ectopic chromosomal amplifications in acute myeloid leukemia cell limes using high-throughput chromosome conformation capture screening
- Treatment of acute myeloid leukemia with inv(3) or t(3;3): A single-center retrospective cohort study and literature review
- Prognostic impact of high-grade transformation in low-grade B-cell lymphomas: a systematic review and meta-analysis
- The diagnostic utility of the soluble CD25-to-ferritin ratio in lymphoma-associated hemophagocytic lymphohistiocytosis
- Inflammation-based scores and their dynamic changes as prognostic indicators in classical hodgkin lymphoma
- Beyond the binding site: PROTAC-mediated protein degradation assists the therapeutic paradigm of hematological malignancies
- O-GlcNAc transferase inhibition sensitizes multiple myeloma cells to regorafenib via G0/G1 cell cycle arrest
- Chronic myeloid leukemia is not a familial disease…or maybe it is?
- Clinicopathologic spectrum of PHF6 mutation across a heterogeneous cohort of myeloid malignancies: A single institution experience
- Ferritin provides prognostic information beyond the iCPSS and BLAST-Mol in patients with CMML
- Cladribine and low-dose cytarabine as first salvage after hypomethylating agent and venetoclax in acute myeloid leukemia
- Approval-standardized postmarketing safety reporting phenotypes of talquetamab versus BCMA-directed bispecific antibodies in multiple myeloma
- NGS-based retrospective profiling of BCR::ABL1 kinase domain mutations in chronic myeloid leukemia: Findings from the largest South Asian cohort
- Real-world effectiveness and safety of fixed-duration frontline venetoclax–obinutuzumab for chronic lymphocytic leukemia: A nationwide multicenter retrospective cohort study
- Financial burden to patients and informal carers of myelodysplastic syndromes in England: a modelled analysis stratified by transfusion dependence
- Pediatric-inspired USC-ALL regimen vs hyper-CVAD in adults with Ph-negative and Ph-like acute lymphoblastic leukemia
- Megakaryopoiesis and its dysregulation in paediatric acute megakaryoblastic leukaemia
- Real-world outcomes of asciminib versus first- and second-generation tyrosine kinase inhibitors as second-line treatment for chronic-phase chronic myeloid leukemia
- Bone marrow gene methylation detection for prognostic evaluation in diffuse large B-cell lymphoma
- The summa of ZUMA: Lessons from a decade of CD19-targeted CAR-T trials in B-cell malignancies
- Longitudinal changes in diamine oxidase activity and gut microbiota in hematopoietic stem cell transplantation recipients
- Idarubicin synergistically enhances NK cell-mediated cytotoxicity by upregulating the AML cell surface ligand ULBP2
- Age over sibling: Younger unrelated donors provide superior outcomes compared to sibling donors in fully matched HCT in older AML/MDS patients
- Timing of ATRA in acute promyelocytic leukemia: When location of presentation alters patient outcomes
- Immune-mediated thrombosis in myeloproliferative neoplasms: Pathogenic pathways and clinical relevance